Filter
8717
Filtered Results: 8717
Text search:
drugs
Featured
Recommendations
718
New Publications
2183
Language
Document type
No document type
5131
Studies & Reports
1280
Guidelines
1071
Manuals
376
Strategic & Response Plan
249
Fact sheets
230
Training Material
133
Situation Updates
74
Infographics
59
Resource Platforms
44
Brochures
39
Online Courses
16
Videos
11
Dashboards/Maps
2
App
2
Countries / Regions
India
488
Global
288
Kenya
251
South Africa
198
Ethiopia
178
Nepal
172
Uganda
166
Western and Central Europe
165
Nigeria
161
Sierra Leone
153
Tanzania
130
Zambia
124
Liberia
123
Malawi
121
Latin America and the Carribbean
120
Rwanda
112
Bangladesh
110
Ghana
107
Ukraine
106
Africa
104
Myanmar / Burma
102
Eastern Europe
87
Indonesia
74
Philippines
71
Namibia
71
Russia
69
Zimbabwe
64
Congo, Democratic Republic of
62
Asia
52
Senegal
51
South–East Asia Region
51
Syria
48
Cambodia
48
Lesotho
47
Germany
47
Mozambique
46
Brazil
43
Burkina Faso
42
Botswana
39
South Sudan
38
Colombia
36
Haiti
36
Venezuela
33
West and Central Africa
31
Eswatini/ Swaziland
31
East and Southern Africa
30
Middle East and North Africa
28
Cameroon
24
Guinea
23
Tajikistan
22
Chile
22
Paraguay
22
Eastern Europe and Central Asia
20
Argentina
20
Benin
19
Peru
19
USA
17
Yemen
17
Albania
16
Afghanistan
16
Sudan
16
Vietnam
15
Moldova
15
Pakistan
15
Bolivia
14
Madagascar
14
China
12
Georgia
12
Central African Republic
12
Thailand
11
Armenia
11
Western Pacific Region
11
Lebanon
11
Somalia
11
North Macedonia
10
Laos
10
North America
9
Ecuador
9
Mexico
8
Mali
8
El Salvador
7
Jordan
7
United Kingdom
7
Sri Lanka
7
Angola
7
Palestine
6
Libya
6
Iraq
6
Serbia
5
Turkey
5
Guinea-Bissau
5
Spain
5
Southern Africa
5
Papua New Guinea
5
Romania
5
Bhutan
5
Iran
4
Fiji
4
Estonia
4
Kyrgyzstan
4
Niger
4
Uzbekistan
4
Burundi
4
Saudi Arabia
4
Jamaica
4
Côte d’Ivoire / Ivory Coast
4
Egypt
4
Poland
4
Switzerland
3
Timor Leste/ East Timor
3
Kazakhstan
3
Morocco
3
Hungary
3
Uruguay
3
Belarus
3
Greece
3
Chad
3
Gambia
2
Canada
2
Singapore
2
Mongolia
2
Qatar
2
Lithuania
2
Ireland
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Djibouti
2
Honduras
2
North Korea
1
Australia
1
Congo-Brazzaville
1
Malaysia
1
Austria
1
Bulgaria
1
Italy
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3380
Clinical Guidelines
729
Public Health
391
Women & Child Health
344
Key Resources
266
Capacity Building
142
Pharmacy & Technologies
90
Annual Report MEDBOX
2
Toolboxes
HIV
916
Mental Health
877
TB
758
COVID-19
499
NTDs
368
AMR
364
Pharmacy
270
NCDs
203
Caregiver
199
Ebola & Marburg
168
Rapid Response
152
Refugee
145
Conflict
128
Disability
119
Planetary Health
119
Global Health Education
86
Health Financing Toolbox
78
Natural Hazards
57
Zika
37
Cholera
35
Polio
29
Specific Hazards
26
Social Ethics
24
Malaria
15
South Sudan
2
Complete version of MDS-3 publication - Managing Drug Supply (MDS) is the leading reference on how to manage essential medicines in developing countries. MDS was originally published in 1982. It was revised in 1997 with over 10,000 copies distributed in over 60 countries worldwide. The third edition...
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monitoring and evaluation framework and outlines the visi...
Antibiotic resistance occurs when bacteria no longer respond to the drugs designed to kill them. Anytime antibiotics are used, they can cause antibiotic resistance.
Resistance happens when germs (bacteria and fungi) defeat the drugs designed to kill them. Any antibiotic use—in people, animals, or crops—can lead to resistance. Resistant germs are a One Health problem—they can spread between people, animals, and the environment.
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The pamphlet "Prescription Benzodiazepines" explains the uses, effects, and risks of benzodiazepines, commonly prescribed for insomnia, anxiety, and panic attacks. It describes how these drugs enhance GABA activity to suppress brain activity, leading to short-term effects like drowsiness and anxiety...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Antibiotics are among the most frequently prescribed classes of drugs and it is estimated that approximately 50% of antibiotic use, in both the outpatient and inpatient settings, is inappropriate. At the same time, in contrast to any other class of drugs, every antibiotic use has a potential public ...
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
Regulation of the President of the Republic of Indonesia on the Implementation of Patents by the Government on Antiviral and Antiretroviral Drugs
Decree of the Minister of Health of the Republic of Indonesia Number 1190 / MENKES / SK / X / 2004 on the Free Drug of Anti Tuberculosis (OAT) and Anti Retro Viral (ARV) Drugs for HIV / AIDS
The Chagas disease data platform is founded upon a collaborative framework that aims to bring together partners including individual researchers in Chagas endemic regions, leading global research institutions, policy specialists and funders from across the globe. The theme is coordinated by a team b...
Монографія має за мету ознайомити громадськість із проектом ESPAD – Європейське опитування учнів щодо вживання алкоголю та інших наркотичних речовин (European School Survey Pr...
UN GUIDE POUR L’APPROVISIONNEMENTEN MÉDICAMENTS/ A guide for drug supply
Bochure in English and French
